Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders.
Brain. 2020 Feb 1;143(2):407-429. doi: 10.1093/brain/awz328.
Brain. 2020.
PMID: 31738395
Review.